Papers
11
Total Citations
218
H-Index
9
About
Patrick Honeck is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for kidney and prostate diseases. He is best known for spearheading the ROBOCOP trials—a landmark series of randomized controlled and propensity-matched studies comparing robot-assisted partial nephrectomy (RAPN) to conventional open surgery. His research has demonstrated that robotic approaches can achieve trifecta outcomes (negative margins, minimal complications, and warm ischemia time) even for completely endophytic renal tumors, challenging traditional limits of minimally invasive surgery. With over 50 citations for his foundational work on endophytic tumors, and the ROBOCOP II trial (39 citations) providing the first randomized evidence in this field, Honeck’s contributions have shaped modern nephron-sparing surgery. He has also advanced benign prostatic hyperplasia treatment through systematic reviews and meta-analyses comparing robot-assisted simple prostatectomy to endoscopic enucleation, and his PELYCAN trial (14 citations) introduced a novel peritoneal flap technique to prevent lymphoceles after prostate cancer surgery. His work consistently emphasizes rigorous comparative effectiveness and quality-of-life outcomes, making him a key figure in evidence-based robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10